West Tower Group’s Select Medical SEM Stock Holding History

West Tower Group’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-165	Closed	-$2.25K	–	725
2023 Q3	$2.25K	Buy	+165	New	+$2.55K	﹤0.01%	567

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

West Tower Group's SEM Position: Q4 2023 in Review

West Tower Group sold out of Select Medical (SEM) in Q4 2023, closing a stake of 165 shares — an estimated $2.25K sold.

West Tower Group first reported a position in SEM in Q3 2023 and held it in 1 quarter. The position peaked at $2.25K in Q3 2023. 248 funds tracked by Wall St. Rank hold SEM as of Q4 2023.

West Tower Group reported no remaining Select Medical position as of Q4 2023 after selling out during the quarter.
West Tower Group sold 165 Select Medical shares in Q4 2023, an estimated $2.25K.
West Tower Group first reported a position in Select Medical in Q3 2023 and held it in 1 quarter.
West Tower Group's Select Medical position peaked at $2.25K in Q3 2023.
248 funds tracked by Wall St. Rank held Select Medical as of Q4 2023.

Based on West Tower Group's 13F filing for Q4 2023, filed 14 Feb 2024.